|
Dr. Dickson has been the Chief Medical Officer of Cornerstone since May 2005. As Cornerstone’s Chief Medical Officer, Dr. Dickson is responsible for developing new products in order to obtain timely regulatory approval, assisting in attaining new products for the company, designing and managing all clinical studies as well as leading negotiations with the FDA. Dr. Dickson has a twenty year background in development at major pharmaceutical and biotech companies. Prior to joining Cornerstone, Dr. Dickson worked in senior management with Smith, Kline & French Laboratories Ltd. from 1978 to 1987, Searle from 1988 to 1991, and Warner Lambert / Parke Davis from 1991 to 1994. Further, he was Chief Medical Officer at the contract research organization Inveresk Ltd. (Charles River Laboratories). Dr. Dickson has led teams that have obtained 18 FDA approvals and has presented at 14 FDA Advisory Boards. In addition to Dr. Dickson’s industry experience, he was a past Editor-in-Chief of the Journal of Pharmaceutical Medicine and is a member of the Faculty of Pharmaceutical Medicine. Dr. Dickson also served as a subcommittee member for nutrition and anemia at the World Health Organization. Dr. Dickson received his Doctor of Medicine from Adelaide University in South Australia. | 